Literature DB >> 2744015

Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.

K Kruse1, U Kracht, K Wohlfart, U Kruse.   

Abstract

In addition to the well-documented hyporesponsiveness of the kidney, resistance to parathyroid hormone (PTH) has been postulated for bone in pseudohypoparathyroidism type I (PHP). In some of these patients reduced bone density and even frank osteitis fibrosa suggest osteoclastic overactivity. To address the possibility that the skeletal system of patients with PHP may be affected by their increased PTH secretion we measured intact serum PTH and three biochemical markers of bone turnover in a large number of patients with PHP (n = 20). The results were compared with subjects with low (hypoparathyroidism, HP n = 29), normal (controls, n = 31) and high (primary hyperparathyroidism, 1 degree HPT, n = 13) PTH secretion. Both markers of osteoblastic bone formation, alkaline phosphatase activity and osteocalcin concentration in serum, and one index of osteoclastic bone degradation, the urinary hydroxyproline/creatinine ratio (OH-P/Cr), were decreased in HP and increased in 1 degree HPT, whereas only OH-P/Cr was elevated in patients with PHP. Although intact serum PTH was significantly more increased in PHP than in 1 degree HPT, the markers of bone turnover were not significantly different in these two groups, suggesting some bone resistance in the patients with PHP. In these subjects intact serum PTH was elevated even at normocalcaemia during vitamin D treatment with a negative correlation with the respective serum calcium concentration (r = -0.69, P less than 0.001), indicating an elevated set-point for the suppression of their parathyroid glands. OH-P/Cr was negatively related to serum calcium in PHP, it normalized in most patients during normocalcaemia induced by vitamin D treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744015     DOI: 10.1007/bf00441552

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Pseudohypoparathyroidism with bone changes simulating hyperparathyroidism. Report of a case.

Authors:  E B SINGLETON; C T TENG
Journal:  Radiology       Date:  1962-03       Impact factor: 11.105

2.  Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa.

Authors:  F O KOLB; H L STEINBACH
Journal:  J Clin Endocrinol Metab       Date:  1962-01       Impact factor: 5.958

3.  A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

4.  Pseudohypoparathyroidism with raised plasma alkaline phosphatase.

Authors:  R D Cohen; F P Vince
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

5.  Hypo-hyperparathyroidism.

Authors:  E H Allen; F J Millard; J R Nassim
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

6.  [Intact serum parathormone (PTH 1-84). A suitable parameter for the diagnosis of calcium metabolism disorders].

Authors:  K Kruse; U Kracht; K Wohlfart; U Kruse
Journal:  Dtsch Med Wochenschr       Date:  1988-02-26       Impact factor: 0.628

7.  Evaluation of serum osteocalcin as an index of altered bone metabolism.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

8.  [Hydroxyproline in morning urine. A reliable parameter for bone turnover in childhood].

Authors:  K Kruse; U Kracht
Journal:  Monatsschr Kinderheilkd       Date:  1983-11       Impact factor: 0.323

9.  Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.

Authors:  N A Breslau; A M Moses; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

10.  Skeletal responsiveness in pseudohypoparathyroidism. A spectrum of clinical disease.

Authors:  G S Kidd; M Schaaf; R A Adler; M N Lassman; H L Wray
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

View more
  8 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Pseudohypoparathyroidism presenting with bony deformities resembling rickets.

Authors:  Anurag Bajpai; Jyoti Sharma; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

3.  PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; James Sliney; Hua Zhou; Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Maryann Dellabadia; Rebecca Ives; Donald J McMahon; Chiyuan Zhang; Shonni J Silverberg; Elizabeth Shane; Serge Cremers; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

4.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

5.  Indices of intact serum parathyroid hormone and renal excretion of calcium, phosphate, and magnesium.

Authors:  N J Shaw; J Wheeldon; J T Brocklebank
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

6.  The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.

Authors:  Mishaela R Rubin; Hua Zhou; Natalie E Cusano; Rukshana Majeed; Beatriz Omeragic; Maximo Gomez; Thomas L Nickolas; David W Dempster; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2018-08-16       Impact factor: 6.741

7.  Calcium metabolism in the Jansen type of metaphyseal dysplasia.

Authors:  K Kruse; C Schütz
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

8.  Dynamic and structural properties of the skeleton in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; Hua Zhou; Elizabeth Shane; Thomas Nickolas; James Sliney; Shonni J Silverberg; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.